perfosfamide has been researched along with Blast Phase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calabretta, B; Malaguarnera, L; Nieborowska-Skórska, M; Ratajczak, MZ; Skórski, T; Szczylik, C | 1 |
| Rosenfeld, CS | 1 |
2 other study(ies) available for perfosfamide and Blast Phase
| Article | Year |
|---|---|
Successful mafosfamide purging of bone marrow from chronic myelogenous leukemia (CML) cells.
Topics: Antineoplastic Agents; Blast Crisis; Bone Marrow; Bone Marrow Purging; Colony-Forming Units Assay; Cyclophosphamide; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Chronic-Phase; Oligonucleotide Probes; Polymerase Chain Reaction; Tumor Cells, Cultured | 1993 |
Antileukemic activity of phenylalanine methyl ester (PME): a lysosomotropic peptide methyl ester.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blast Crisis; Child; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Monocytes; Phenylalanine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temperature; Tumor Cells, Cultured | 1994 |